ImageneBio, Inc.
IMA
$5.83
-$0.19-3.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -77.14% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -77.14% | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -77.14% | -- | -- | -- | |
| SG&A Expenses | 147.00% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 21.61% | -- | -- | -- | |
| Operating Income | -30.95% | -- | -- | -- | |
| Income Before Tax | -25.01% | -- | -- | -- | |
| Income Tax Expenses | -2,792.31% | -- | -- | -- | |
| Earnings from Continuing Operations | -24.01% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -24.01% | -- | -- | -- | |
| EBIT | -30.95% | -- | -- | -- | |
| EBITDA | -33.99% | -- | -- | -- | |
| EPS Basic | -87.39% | -- | -- | -- | |
| Normalized Basic EPS | -178.38% | -- | -- | -- | |
| EPS Diluted | -87.39% | -- | -- | -- | |
| Normalized Diluted EPS | -178.38% | -- | -- | -- | |
| Average Basic Shares Outstanding | 46.95% | -- | -- | -- | |
| Average Diluted Shares Outstanding | -25.76% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |